Anderson K, Cañadas-Garre M, Chambers R, et al. (2019) The challenges of chromosome Y analysis and the implications for chronic kidney disease. Frontiers in Genetics 10:781.
Aykanat B, Demircigil G, Fidan K, et al.(2011)Basal damage and oxidative DNA damage in children with chronic kidney disease measured by use of the comet assay.Mutation Research 725(1-2):22-28.
Bikbov B, Purcell CA, Levey AS, et al.(2020) Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet 395(10225):709-733.
Cañadas-Garre M, Anderson K, McGoldrick J, et al. (2018) Genomic approaches in the search for molecular biomarkers in chronic kidney disease. Journal of Translational Medicine 16(1):292.
Chang CC, Chiu PF, Wu CL, et al. (2019) Urinary cell-free mitochondrial and nuclear deoxyribonucleic acid correlates with the prognosis of chronic kidney diseases. BMC Nephrology 20(1):391.
Coimbra S, Rocha S, Nascimento H, et al.(2020) Cell-free DNA as a marker for the outcome of end-stage renal disease patients on haemodialysis. Clinical Kidney Journalsfaa115, https://doi.org/10.1093/ckj/sfaa115.
Coll E, Stoyanova E, Rodríguez-Ribera L, et al. (2013) Genomic damage as an independent predictor marker of mortality in hemodialysis patients. Clinical Nephrology 80(2): 81-87.
Del Vecchio L, Locatelli F and Carini M (2011) What we know about oxidative stress in patients with chronic kidney disease on dialysis--clinical effects, potential treatment, and prevention. Seminars in Dialysis 24(1):56-64.
Demircigil G, Aykanat B, Fidan K, et al. (2011) Micronucleus frequencies in peripheral blood lymphocytes of children with chronic kidney disease. Mutagenesis 26(5):643-650.
Dwivedi RS, Herman JG, McCaffrey TA, et al. (2011) Beyond genetics: epigenetic code in chronic kidney disease. Kidney International 79(1):23-32.
Ersson C, Thorman R, Rodhe Y, et al. (2011) DNA damage in salivary gland tissue in patients with chronic kidney disease, measured by the comet assay. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontic112(2):209-215.
Fenech M (2000) The in vitro micronucleus technique. Mutation Research 455: 81-95.
Ganguly BB, Mandal S, Banerjee N, et al. (2018) Effect of age at exposure on chromosome abnormalities in MIC-exposed Bhopal population detected 30years post-disaster. Mutation Research 809:32-50.
Ganguly BB, Mandal S and Kadam NN (2018) Spectrum of health condition in methyl isocyanate (MIC)-exposed survivors measured after 30 years of disaster. Environmental Science and Pollution Research International 25(5):4963-4973.
Ganguly BB and Mandal S(2017) Cytogenetic changes in the Bhopal population exposed to methyl isocyanate (MIC) in 1984: Then and 30 years later. Mutation Research 824:9-19.
Ganguly BB (2019) Exposure index of methyl isocyanate (MIC) gas disaster and a comprehensive spectrum of cytogenetic analysis after 30 years. Environmental Science and Pollution Research International 26(18):18208-18229.
Ganguly BB, Mandal S and Kadam NN(2019) Frequency of micronuclei in population of Bhopal exposed to methyl isocyanate in 1984. The Nucleus 62: 269 - 275.
Ghosh BB, Sengupta S, Roy A, et al. (1990)Cytogenetic studies in human populations exposed to gas leak at Bhopal, India. Environmental Health Perspectives 86:323-326.
Goswami HK, Chandorkar M, Bhattacharya K, et al.(1990)Search for chromosomal variations among gas-exposed persons in Bhopal. HumanGenetics 84:172–176.
Goswami HK, Guron C, Jain N, et al. (1984) Genetic assessment of Union Carbide gas tragedy in Bhopal. I. Effects on somatic chromosomes and haemoglobin. Bionature 4:88–90.
Goswami HK (1986) Cytogenetic effects of methyl isocyanate exposure in Bhopal. Human Genetics 74:81–84.
Guido M, Zizza A, Tumolo MR, et al. (2016) Using the cytokinesis-block micronucleus cytome assay to evaluate chromosomal DNA damage in chronic renal patients undergoing bicarbonate haemodialysis and haemodiafiltration. Journal of Preventive Medicine and Hygiene57(3):E178-E184.
Hagmar L, Strömberg U, Bonassi S, et al.(2004) Impact of types of lymphocyte chromosomal aberrations on human cancer risk: results from Nordic and Italian cohorts. Cancer Research 64(6):2258-2263.
Hruska KA, Choi ET, Memon I, et al. (2010) Cardiovascular risk in chronic kidney disease (CKD): the CKD-mineral bone disorder (CKD-MBD). Pediatric Nephrology 25(4):769-778.
İpek E, Ermiş E, Uysal H, et al. (2017) The relationship of micronucleus frequency and nuclear division index with coronary artery disease SYNTAX and Gensini scores. Anatolian Journal of Cardiology 17(6):483-489.
Jha V, Garcia-Garcia G, Iseki K, et al. (2013) Chronic kidney disease: global dimension and perspectives. The Lancet 382(9888):260-272.
Karaman A and Keskinler F (2009) Genomic damage in patients with chronic renal failure. Turkiye Klinikleri Journal of Medical Sciences 29(6):1392-1397.
Khan Z, Pandey M and Samartha RM (2016) Role of cytogenetic biomarkers in management of chronic kidney disease patients: A review. International Journal of Health Sciences 10(4):576-589.
Konat GW (2003) H2O2-induced higher order chromatin degradation: a novel mechanism of oxidative genotoxicity. Journal of Biosciences 28 (1):57-60.
Levey AS and Coresh J (2012) Chronic kidney disease. The Lancet 379(9811):165-180.
Li PK, Garcia-Garcia G, Lui SF, et al. (2020) World Kidney Day Steering Committee; Members of the World Kidney Day Steering Committee. Kidney Health for Everyone Everywhere - From prevention to detection and equitable access to care. Nefrologia 40(2):133-141.
Lialiaris T, Mavromatidou P, Digkas E, et al. (2010) Chromosome instability in patients with chronic renal failure. Genetic Testing and Molecular Biomarkers 14(1):37-41.
Locatelli F, Canaud B, Eckardt KU, et al. (2003) Oxidative stress in end- stage renal disease: an emerging threat to patient outcome. Nephrology Dialysis Transplantation 18(7):1272-1280.
Luttropp K, Lindholm B, Carrero JJ, et al. (2009)Genetics/Genomics in chronic kidney disease-towards personalized medicine?Seminars in Dialysis 22(4):417-22.
Malla TM, Senthilkumar CS, Sharma NC, et al. (2011) Chromosome instability among Bhopal gas tragedy survivors. American-Eurasian Journal of Toxicological Sciences 3:245-249.
Malla TM, Sharma NC and Ganesh N (2010) Frequency of acrocentric associations in Bhopal gas tragedy survivors. International Journal of Cell and Molecular Biology 1: 26-30.
Mamur S, Unal F, Altok K, et al. (2016) DNA damage in hemodialysis patients with chronic kidney disease; a test of the role of diabetes mellitus; a comet assay investigation. Mutation Research/Genetic Toxicology and Environmental Mutagenesis 800:22-27.
Mishra PK, Samarth RM, Pathak N, et al. (2009) Bhopal Gas Tragedy: Clinical and Experimental Findings, view after 25 years. International Journal of Occupational Medicine and Environmental Health 22:193-202.
National Cancer Registry Programme ICMR (2005) Two-year Report of the Population Based Cancer Registries (1999-2000).
Orr SE and Bridges CC (2017)Chronic kidney disease and exposure to nephrotoxic metals. International Journal of Molecular Sciences18(5):1039.
Palazzo RP, Bagatini PB, Schefer PB, et al. (2012) Genomic instability in patients with type 2 diabetes mellitus on hemodialysis. Revistabrasileira de Hematologia e Hemoterapia. 34(1):31-35.
Quintero Ojeda JE, Aguilar-Medina M, Olimón-Andalón V, et al. (2018) Increased micronuclei frequency in oral and lingual epithelium of treated diabetes mellitus patients. BioMed Research International2018.
Rajapurkar MM, John GT, Kirpalani AL, et al. (2012)What do we know about chronic kidney disease in India: first report of the Indian CKD registry.BMC Nephrology 13:10.
Rangel-López A, Paniagua-Medina ME, Urbán-Reyes M, et al. (2013)Genetic damage in patients with chronic kidney disease, peritoneal dialysis and haemodialysis: a comparative study. Mutagenesis 28(2):219-225.
Reddy MA and Natarajan R(2015)Recent developments in epigenetics of acute and chronic kidney diseases. Kidney International 88(2):250-261.
Rodríguez Ribera L, Stoyanova E, Corredor Z, et al. (2014) Time in hemodialysis modulates the levels of genetic damage in hemodialysis patients. Environmental and Molecular Mutagenesis55(4):363-8.
Rooney DE and Czepulkowski BH (1992) Human Cytogenetics: A Practical Approach. 2nd ed., Vol. 1, 2. Oxford, New York: IRL Press at Oxford University Press.
Roth JM, Restani RG, Gonçalves TT, et al. (2008) Genotoxicity evaluation in chronic renal patients undergoing hemodialysis and peritoneal dialysis, using the micronucleus test. Genetics and Molecular Research 7(2):433-443.
Sabharwal R, Verma P, Syed MA, et al. (2015) Emergence of micronuclei as a genomic biomarker. Indian Journal of Medical and Paediatric Oncology 36(4):212-218.
Samarth RM, Gandhi P,Pandey H, et al. (2012) Mosaicism for trisomy 21 and ring (21) in a male born to normal parents: A case report. Gene 511: 109-112.
Samarth RM, Gandhi P and Maudar KK (2013) Retrospective review of cytogenetic studies on Methyl Isocyanate with special reference to Bhopal Gas Tragedy: Is the next generation also at risk? International Journal of Occupational Medicine and Environmental Health 26 (3): 324-336.
Samarth RM, Khan T, Srivas S, et al. (2018) Evaluation of cyclophosphamide-induced genotoxicity and cytotoxicity in cultured human lymphocytes. Journal of Radiation and Cancer Research 9: 28-32.
Schiffrin EL, Lipman ML and Mann JF (2007) Chronic kidney disease: effects on the cardiovascular system. Circulation116(1):85-97.
Schupp N, Heidland A and Stopper H (2010) Genomic damage in end stage renal disease-contribution of uremic toxins. Toxins 2(10):2340-2358.
Senthilkumar CS, Malla TM, Sah NK, et al. (2013)Methyl isocyanate exposure and atypical lymphocytes.The International Journal of Occupational and Environmental Medicine 4(3):167-168.
Shrivastava R (2011)Bhopal gas disaster: Review on health effects of methyl isocyanate. Research Journal of Environmental Science 5(2):150–156.
Sriramachari S (2004)The Bhopal gas tragedy: An environmental disaster. Current Science 86:905–920.
Targher G and Byrne CD(2017) Non-alcoholic fatty liver disease: an emerging driving force in chronic kidney disease. Nature Reviews Nephrology 13(5):297-310.
Targher G, Chonchol M, Zoppini G, et al. (2011) Risk of chronic kidney disease in patients with non-alcoholic fatty liver disease: is there a link? Journal of Hepatology54(5):1020-1029.